Skip to content
Screener

Organon OGN Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Amgen logo
AmgenAMGN
$12.98B+17.7%
Pfizer logo
PfizerPFE
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
Biogen logo
BiogenBIIB
AbbVie logo
AbbVieABBV
Opko Health logo
Opko HealthOPK

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.57B+52.5%
Enterprise value$11.02B+3.6%
P/E6.6×+2.1×
P/S0.6×+0.2×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent.

The source filing: Organon’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 8:46 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-029532
Line itemMarch 31, 2026December 31, 2025
Property, plant and equipment, net1,2791,303
Goodwill4,1534,153
Intangibles, net1,0991,130
Other assets1,5331,539
Noncurrent assets held for sale390
Total Assets$12,996$12,867
Liabilities and Equity
Current Liabilities:

Item 1. Financial Statements (unaudited)

FAQ

What is Organon's deferred tax assets and other non-current assets?
Organon (OGN) reported deferred tax assets and other non-current assets of $1.53B in Q1 2026.
How has Organon's deferred tax assets and other non-current assets changed year-over-year?
Organon's deferred tax assets and other non-current assets increased by 2.8% year-over-year, from $1.49B to $1.53B.
What is the long-term trend for Organon's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Organon's deferred tax assets and other non-current assets has grown at a 111.9% compound annual growth rate (CAGR), from $36M to $1.54B.

Ask your AI about Organon's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude